SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,209,959 | -74.9% | 58,793 | -42.7% | 0.00% | -75.0% |
| Q2 2023 | $4,826,273 | +21.8% | 102,643 | +8.7% | 0.01% | +14.3% |
| Q1 2023 | $3,962,828 | +18.6% | 94,443 | +7.8% | 0.01% | +16.7% |
| Q4 2022 | $3,339,996 | -12.5% | 87,572 | -10.2% | 0.01% | -14.3% |
| Q3 2022 | $3,819,000 | +61.6% | 97,533 | +33.3% | 0.01% | +75.0% |
| Q2 2022 | $2,363,000 | -4.1% | 73,166 | -1.7% | 0.00% | +33.3% |
| Q1 2022 | $2,463,000 | -24.1% | 74,426 | -2.4% | 0.00% | -25.0% |
| Q4 2021 | $3,243,000 | – | 76,237 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
| DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
| Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
| BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
| Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
| TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
| OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |